|
|
|
|
|
Hana Biosciences posts trimmer 1Q loss lower costs
- 86 Minutes ago
|
|
|
|
SOUTH SAN FRANCISCO, Calif. Biotech drug developer Hana Biosciences said Tuesday it posted a slimmer first-quarter loss due to lower costs. The company lost $6.3 million, or 19 cents per share, compared
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing Glance: Health stocks close mixed
- 6 Hours ago
|
|
|
|
NEW YORK Shares of health care providers and service companies were mixed Monday, with several insurers losing ground, while the broader market posted solid gains. Results from Monday trading in the sector
|
|
|
|
|
|
|
|
|
|
|
|
|
Gene therapy shows promise in rare brain disease
- 79 Minutes ago
|
|
|
|
WASHINGTON (Reuters) - An experimental gene therapy treatment appears to have helped eight children with a rare and incurable neurological disorder, although it may have been responsible for the death
|
|
|
|
|
|
|
|
|
|
|
|
|
Crunch time - a definitive guide to the credit crunch
- 7 Hours ago
|
|
|
|
The phrase 'When the US sneezes, the rest of the world catches a cold' has arguably never been quite so true. When the first mention of a US sub-prime crisis began making its way into the headlines, I
|
|
|
|
|
|
|
|
|
|
|
|
|
Opening Glance: Biotechnology shares fall
- 8 Hours ago
|
|
|
|
NEW YORK - Shares of biotechnology companies opened lower Tuesday as the broader market fell slightly as the Commerce Department reported a dip in April retail sales. How shares of several key biotechnology
|
|
|
|
|
|
|
|
|
|
|
|
|
Cypress Bioscience 1Q loss widens on expenses
- 9 Hours ago
|
|
|
|
SAN DIEGO, Calif. Cypress Bioscience Inc. Monday said that its first-quarter loss widened on an increase in operating expenses stemming from the drug developer's acquisition of Propius Pharmaceuticals.
|
|
|
|
|
|
|
|
|
|
|
|
|